go back

Melanoma Versus Benign Mole Gene Test

Washington, DC rates for HCPCS 0314U

Helps decide whether a skin lesion is a melanoma or a harmless mole when its appearance under the microscope is not clear cut. The activity of 35 genes is measured in the stored tissue sample and the lesion is classified accordingly. A companion test instead judges the outlook for squamous cell skin cancers.

Rates data updated July 2026.

Facilitymedian $1,479 · 10th–90th $1,479$3,3110%50%90th$1,479Professionalmedian $1,479 · 10th–90th $1,413$1,5140%50%10th90th$1,479$2.0$10.0$50.0$200.0$1.0K$5.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$1,479.11
Median
$1,479.11
Typical High
$1,479.11
Aetna
Setting
Professional
Modifier
Global
Typical Low
$1,445.44
Median
$1,479.11
Typical High
$1,513.56
CareFirst
Setting
Professional
Modifier
Global
Typical Low
$1,412.54
Median
$1,412.54
Typical High
$1,862.09
Cigna
Setting
Facility
Modifier
Global
Typical Low
$3,311.31
Median
$3,311.31
Typical High
$7,413.10
Cigna
Setting
Professional
Modifier
Global
Typical Low
$2,238.72
Median
$2,238.72
Typical High
$2,511.89
Kaiser Permanente
Setting
Professional
Modifier
Global
Typical Low
$2,238.72
Median
$2,238.72
Typical High
$3,981.07
United
Setting
Facility
Modifier
Global
Typical Low
$812.83
Median
$2,344.23
Typical High
$2,344.23
United
Setting
Professional
Modifier
Global
Typical Low
$812.83
Median
$870.96
Typical High
$1,819.70